
    
      Newly diagnosed WM patients will be randomly assigned to BCD or RCD group for introduction
      chemotherapy. Chemotherapeutic response will be evaluated after 3 cycles. If a PR or better
      response achieves, addition 3 cycles will be given. If not, patients will be crossed to
      control group for another 3 cycles. If a PR or better response comes out, addition 3 cycles
      will be given, otherwise, the patients will quit this study.
    
  